Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$36.95 - $82.41 $279,009 - $622,277
-7,551 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$55.7 - $145.79 $420,590 - $1.1 Million
7,551 New
7,551 $574,000
Q3 2021

Nov 15, 2021

SELL
$145.58 - $192.14 $275,582 - $363,721
-1,893 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$134.22 - $202.37 $254,078 - $383,086
1,893 New
1,893 $371,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.